Weight loss jabs like Ozempic can cut the risk of heart attacks or strokes by a fifth, a “game-changing” new study has found. The anti-obesity injections could reduce the risk in obese people ...
Anti-obesity jabs could reduce the risk of heart attacks, strokes or heart failure in obese people regardless of the amount of weight they lose while on the drug, researchers have found.
Weight loss jabs cut the risk of heart death by a fifth, a study has found, with medics calling for them to be prescribed like statins. The research – the largest ever trial of the injections ...
Doctors say it will be the 'icing on the cake' if the medicines, which have been shown to cut heart attack and strokes, had a ...
Obesity jabs could cut the risk of heart attacks and strokes in people even if they fail to lose much weight, according to an ...
The revolutionary jabs were a hot topic as more than 40,000 cancer experts gathered in Chicago for the world's largest cancer ...
Weight loss injections like Ozempic might be a game-changer for heart health. A new study suggests these drugs can significantly reduce the risk of heart attacks and strokes in obese patients ...
FAT jabs could be the cancer hope of the future after early studies found they reduce the risk of tumours. The world’s top ...
Weight loss drugs such as Ozempic and Wegovy could cut the risk of obesity-related cancers by a fifth and bowel cancer by ...
But investors seeking exposure through two newly launched weight-loss exchange traded funds need to ask if they are the best way to gain exposure to this generation of drugs, industry observers say.
The rise in obesity has been accompanied by a rise in interest in anti-obesity drugs. The main weight loss medication used in ...